Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Fujifilm boosts gene-therapy activity at Texas center

by Rick Mullin
November 23, 2019 | A version of this story appeared in Volume 97, Issue 46

 

Fujifilm will invest $120 million at its Diosynth Biotechnologies contract-services campus in College Station, Texas, with the addition of a 6,000 m2 building, including laboratories dedicated to gene-therapy research. The company will also expand current good manufacturing practice capacity at the site with eight single-use bioreactors ranging from 500 to 2,000 L. It has offered gene-therapy fill-and-finish services at College Station since early 2019.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.